Track topics on Twitter Track topics that are important to you
iSchemaView expands RAPID’s worldwide reach and brings the Kingdom of Saudi Arabia the only clinically validated, next-generation imaging platform for assessing ischemic stroke
iSchemaView, the worldwide leader in advanced imaging for stroke, has received approval from the Kingdom of Saudi Arabia’s Ministry of Health (MOH), for the use of the RAPID imaging platform across the Kingdom of Saudi Arabia. RAPID is designed to provide physicians with fast, fully automated, and easy-to-interpret imaging that facilitates clinical decision-making around stroke.
Hospitals and clinics that treat ischemic stroke in the Kingdom of Saudi Arabia will now have access to RAPID’s automated CTP, MR, CTA and ASPECTS solutions, as well as their unique mobile app that accelerates the provision of information to support treatment decision making. RAPID’s expansion into Saudi Arabia represents continued market growth across the Middle East and is further confirmation that RAPID has become the de facto standard for stoke imaging around the world.
“With RAPID’s AI framework and advanced imaging technology we aim to help increase the number of patients that can be successfully treated for stroke within the Kingdom of Saudi Arabia,” said Simon Canham, iSchemaView Vice President & General Manager EMEA. “Moving forward the country's physicians will be able to aide performance by making life-saving decisions faster and more easily, improving patient outcomes and lives.”
Developed by leading stroke experts, RAPID technology has been selected for use in several ground-breaking trials that have changed treatment guidelines issued by both the American Heart Association and American Stroke Association. The RAPID Artificial Intelligence framework combines deep learning, machine learning and expert feature extraction. Together these provide unparalleled sensitivity and specificity across stroke modules (CT perfusion, MR diffusion and perfusion, CTA and CT ASPECT scoring). Results are then delivered by the RAPID Intelligence Services Platform via PACS, email, SMS/MMS, the RAPID app or corporate partner workflow systems.
Unique in the comprehensive depth and range of its clinical validation, RAPID is now also the imaging standard in stroke research. iSchemaView’s imaging solution now has a research footprint across more than 300 stroke centers and more than 10 large-scale international clinical trials. RAPID has been shown to aid in the selection of patients in early and late-window stroke trials, including SWIFT PRIME, EXTEND IA, DAWN, DEFUSE 3 and EXTEND, and has been granted FDA clearance for selection of patients for both early and late window thrombectomy.
The Complete RAPID Platform includes:
“Our commitment to transforming stroke care across the globe continues as we provide more and more healthcare professionals with the most comprehensive and intuitive suite of brain imaging solutions available today,” said Don Listwin, CEO of iSchemaView. “With the approval of RAPID in the Kingdom of Saudi Arabia, we are greatly expanding the number of facilities in the Middle East that are able to address stroke patients with the only clinically validated, next-generation imaging technology.”
For more information about working with RAPID in the Kingdom of Saudi Arabia, contact email@example.com.
iSchemaView is the worldwide leader in advanced imaging for stroke. Installed in over 1,000 hospitals, iSchemaView’s RAPID (automated CTP, MRI, CTA and ASPECTS), with enhanced AI framework, is the most advanced stroke imaging platform. In clinical trials, RAPID has been shown to aid in the selection of patients in early and late-window stroke trials, including SWIFT PRIME, EXTEND IA, DAWN, DEFUSE 3 and EXTEND. In addition to achieving the best clinical outcomes and largest treatment effects ever obtained, these landmark studies led to new American Heart Association and American Stroke Association guidelines and have dramatically altered the management of acute stroke around the world. For more information, visit www.RAPID.ai
Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...
Stroke - Cerebrovascular Disease (CVA)
A stroke is a serious medical condition that occurs when the blood supply to part of the brain is cut off. Strokes are a medical emergency and prompt treatment is essential because the sooner a person receives treatment for a stroke, the less damage is ...